Immunotherapy & Immuno-Oncology
Part of Healthcare - Oncology
 JNJ | Johnson & Johnson | $0.6t | $253.43 | +1.1% | 7.5M |
 ABBV | ABBVIE INC. | $444.6b | $254.84 | +0.0% | 5.2M |
 MRK | Merck & Co., Inc. | $317.4b | $127.63 | +0.0% | 10.7M |
 AZN | AstraZeneca PLC | $294.1b | $168.97 | +0.2% | 1.8M |
 AMGN | Amgen Inc | $195.4b | $366.34 | -1.5% | 2.1M |
 BMY | Bristol-Myers Squibb Co. | $117.7b | $60.74 | +0.5% | 9.8M |
 REGN | Regeneron Pharmaceuticals Inc | $65.4b | $676.50 | -0.3% | 479.2K |
 MRNA | Moderna, Inc. Common Stock | $27.8b | $61.63 | -2.1% | 3.9M |
 RPRX | Royalty Pharma plc Class A Ordinary Shares | $24.9b | $58.31 | -0.6% | 2.2M |
 IBRX | ImmunityBio, Inc. Common Stock | $9.2b | $7.69 | +2.8% | 8.3M |
 ACLX | Arcellx, Inc. Common Stock | $6.7b | $115.06 | -0.0% | 16.1M |
 CGON | CG Oncology, Inc. Common stock | $6.3b | $71.87 | +3.3% | 781.0K |
 RCUS | Arcus Biosciences, Inc. | $3.9b | $27.36 | +2.7% | 610.0K |
 SLS | SELLAS Life Sciences Group, Inc. Common Stock | $2.9b | $13.33 | +12.1% | 10.8M |
 NKTR | Nektar Therapeutics | $2.4b | $68.23 | +1.7% | 450.0K |
 PGEN | Precigen, Inc. Common Stock | $2.0b | $5.00 | 0.0% | 2.6M |
 BCAX | Bicara Therapeutics Inc. Common Stock | $2.0b | $27.93 | +0.5% | 385.9K |
 SNDX | Syndax Pharmaceuticals, Inc. | $1.9b | $22.33 | +0.4% | 782.9K |
 IOVA | Iovance Biotherapeutics, Inc. Common Stock | $1.9b | $5.04 | +7.2% | 22.3M |
 INBX | Inhibrx Biosciences, Inc. Common Stock | $1.4b | $88.00 | -2.2% | 222.7K |
 IMTX | Immatics N.V. Ordinary Shares | $1.4b | $9.58 | +2.4% | 366.6K |
 CRVS | Corvus Pharmaceuticals, Inc. | $1.3b | $14.89 | +4.3% | 684.2K |
 XNCR | Xencor, Inc. | $1.2b | $17.98 | +16.8% | 1.3M |
 CGEM | Cullinan Therapeutics, Inc. Common Stock | $1.1b | $17.58 | +7.7% | 516.8K |
 JANX | Janux Therapeutics, Inc. Common Stock | $0.9b | $15.88 | +2.7% | 639.6K |
 REPL | Replimune Group, Inc. | $0.9b | $9.66 | +7.5% | 3.5M |
 CTMX | CytomX Therapeutics, Inc. | $0.8b | $3.59 | -1.5% | 3.2M |
 CADL | Candel Therapeutics, Inc. Common Stock | $0.8b | $10.25 | +7.3% | 2.2M |
 AURA | Aura Biosciences, Inc. Common Stock | $0.7b | $6.97 | +1.3% | 302.8K |
 OMER | Omeros Corporation | $0.7b | $9.63 | +5.0% | 1.0M |
 CBIO | Crescent Biopharma, Inc. Common Stock | $496.3m | $14.71 | -2.2% | 283.6K |
 INDP | Indaptus Therapeutics, Inc. Common Stock | $399.7m | $2.60 | -1.8% | 14.6K |
 CMPX | Compass Therapeutics, Inc. Common Stock | $394.4m | $2.07 | -1.9% | 1.6M |
 GLSI | Greenwich LifeSciences, Inc. | $344.4m | $16.89 | -15.8% | 321.1K |
 MGNX | MacroGenics, Inc. | $293.7m | $4.36 | +8.9% | 833.9K |
 ALXO | ALX Oncology Holdings Inc. Common Stock | $278.5m | $2.10 | +1.9% | 708.7K |
 CHRS | Coherus Oncology, Inc. Common Stock | $215.9m | $1.43 | +0.7% | 498.6K |
 CGEN | Compugen Ltd | $202.4m | $2.36 | +1.7% | 152.6K |
 HURA | TuHURA Biosciences, Inc. Common Stock | $149.0m | $2.24 | +1.6% | 147.0K |
 GNLX | Genelux Corporation Common Stock | $135.0m | $2.87 | +1.8% | 73.8K |
 CUE | Cue Biopharma, Inc. | $132.6m | $31.25 | +12.1% | 117.0K |
 AGEN | Agenus Inc. | $127.4m | $5.00 | +0.2% | 1.6M |
 ONCY | Oncolytics Biotech, Inc. Common Shares | $113.4m | $0.85 | -3.3% | 1.2M |
 ANIX | Anixa Biosciences, Inc. | $95.3m | $3.46 | +1.2% | 171.6K |
 MAIA | MAIA Biotechnology, Inc. | $87.6m | $1.32 | -2.3% | 479.3K |
 ELTX | Elicio Therapeutics, Inc. Common Stock | $74.6m | $3.18 | -2.8% | 734.0K |
 BYSI | BeyondSpring Inc. Ordinary Shares | $72.0m | $1.25 | 0.0% | 10.4K |
 XBIT | XBiotech Inc | $70.1m | $2.30 | -0.4% | 58.6K |
 XLO | Xilio Therapeutics, Inc. Common Stock | $63.0m | $8.86 | -1.1% | 55.0K |
 TIL | Instil Bio, Inc. Common Stock | $52.2m | $7.43 | -0.8% | 8.5K |